eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | scleroderma |
| Comorbidity | C0020542|pulmonary hypertension |
| Sentences | 12 |
| PubMedID- 20335527 | The presence of the hla-b35 allele has emerged as an important risk factor for the development of isolated pulmonary hypertension in patients with scleroderma, however the mechanisms underlying this association have not been fully elucidated. |
| PubMedID- 20973920 | Our goal is to identify differentially expressed genes in peripheral blood mononuclear cells in scleroderma patients with and without pulmonary hypertension as biomarkers of disease. |
| PubMedID- 21844142 | The multicenter pharos registry (pulmonary hypertension assessment and recognition of outcomes in scleroderma) prospectively follows subjects with ssc at high risk for or with incident pulmonary hypertension (ph). |
| PubMedID- 26210782 | Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the pulmonary hypertension assessment and recognition of outcomes in scleroderma (pharos) registry. |
| PubMedID- 23042670 | We sought to assess the construct validity and responsiveness of the ucsd sobq in systemic sclerosis (ssc; scleroderma) patients with incident pulmonary hypertension (ph) and those at high risk of developing ph. |
| PubMedID- 20862337 | The prevalence of pulmonary hypertension associated with scleroderma ranged from 4.9% to 38% as written in the accp guidelines. |
| PubMedID- 23983198 | Methods: the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry is a prospective registry of ssc patients at high risk for pah or with definite pulmonary hypertension diagnosed by right-sided heart catheterization within 6 months of enrollment. |
| PubMedID- 21597395 | Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia. |
| PubMedID- 22836630 | The present study was aimed at testing the prevalence of anti-endothelial cell antibodies (aeca) in systemic scleroderma (ssc) patients with and without pulmonary hypertension (ph) and in relation to the presence of pulmonary fibrosis. |
| PubMedID- 25356253 | Gastric antral vascular ectasia (gave) has been reported very rarely in imatinib-treated gastrointestinal stromal tumor (gist) and scleroderma patients treated with imatinib for pulmonary hypertension. |
| PubMedID- 21548946 | Furthermore, it has been shown that gdf-15 serum levels are increased in scleroderma patients with pulmonary hypertension and gdf-15 protein was predominantly located in monocytes infiltrating the lung tissue [18]. |
| PubMedID- 22549387 | Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. |
Page: 1